Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 5, 2003, Pages 1489-1497

  Yarbrough, William M ^a   Mukherjee, Rupak ^a   Escobar, G Patricia ^a   Mingoia, Joseph T ^a   Sample, Jeffrey A ^a   Hendrick, Jennifer W ^a   Dowdy, Kathryn B ^a   McLean, Julie E ^a   Stroud, Robert E ^a   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARIPORIDE; CREATINE KINASE MB; HEART ENZYME; SODIUM CHLORIDE; SODIUM PROTON EXCHANGE PROTEIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RANDOMIZATION; STAINING; SYSTOLIC BLOOD PRESSURE;

EID: 10744226192     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00811-0     Document Type: Article

References (30)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988:2:349-60.
2. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-8.
3. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76:1713-9.
4. Wang QD, Pernow J, Sjoquist PO, Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res. 2002;55:25-37.
5. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949-56.
6. Zhao ZQ, Nakamura M, Wang NP, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 2000;45:651-60.
7. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs. 2001;61:375-89.
8. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-42.
9. + exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol. 1993;109:562-8.
10. 2+ overload and impairs function in anoxic rat heart. J Mol Cell Cardiol. 1990;22:57-72.
11. (2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res. 2002;55:739-48.
12. i and diastolic function after ischemia during reperfusion in pig hearts in situ. Am J Physiol Heart Circ Physiol. 2001;280:H830-4.
13. + exchange. Cardiovasc Res. 1997;35:80-9.
14. + exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation. 2000;102:1977-82.
15. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation. 1995;92:912-7.
16. + exchange inhibitor reduces infarct size in pigs. Cardiovasc Res. 1995;30:945-51.
17. Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before of after coronary artery occlusion. J Pharmacol Exp Ther. 1998;286:175-83.
18. (+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation. 1999;100:2519-26.
19. Buerke M, Rupprecht HJ, vom Dahl J, et al. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol. 1999;83:19G-22.
20. (+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation. 2000;101:2902-8.
21. (+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001;38:1644-50.
22. Theroux P, Chaitman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 2000;102:3032-8.
23. Weaver ME, Pantely GA, Bristow JD, Ladley HD. A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res. 1986;20:907-17.
24. Ytrehus K, Liu Y, Tsuchida A, et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol. 1994;267:H2383-90.
25. Ergul A, Walker CA, Goldberg A, et al. ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol Heart Circ Physiol. 2000;278:H2050-6.
26. + concentration. A molecular basis for the antagonistic effect of ouabain and amiloride on the heart. J Biol Chem. 1984;259:8880-5.
27. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:10G-7.
28. Pearl JM, Nelson DP, Wagner CJ, Lombardi JP, Duffy JY. Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. Ann Thorac Surg. 2001;72:565-70.
29. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000;102:2434-40.
30. + exchanger activity. Basic Res Cardiol. 2001;96:301-5.